The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
about
AID and APOBECs span the gap between innate and adaptive immunitySuppression of APOBEC3-mediated restriction of HIV-1 by VifSAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F.Macaques as model hosts for studies of HIV-1 infectionCTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeGANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivityHuman APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.Immunogenetics of small ruminant lentiviral infectionsLower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cellsEscape from highly effective public CD8+ T-cell clonotypes by HIVComplement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.HIV Restriction Factors and Mechanisms of Evasion.AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.APOBEC3 Proteins in Viral Immunity.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinThe antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1.Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T Cells.APOBEC3 proteins can copackage and comutate HIV-1 genomes.Mechanisms of HIV-1 Control.Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.The role of MHC class I gene products in SIV infection of macaques.Elucidation of the time course of adenosine deaminase APOBEC3G and viral infectivity factor vif in HIV-2(287) -infected infant macaques.Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.APOBEC3G is increasingly expressed on the human uterine cervical intraepithelial neoplasia along with disease progression.Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.The role of cytidine deaminases on innate immune responses against human viral infections.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
P2860
Q21131084-47F6081B-DA94-413B-889F-0BB6C8B7DB7EQ27025150-FC58BB59-B030-46FB-B6FB-A01EB4798B3FQ27321665-C9B27C4E-F434-4D80-AB4A-66F67823C905Q30418622-6AB26096-A1CB-4006-91FD-463E33A2F300Q30653348-9654EC32-912F-451C-9550-BFE7187089E7Q31010282-DBE8F294-1CBF-4549-A091-4C6BA5DD0486Q33862780-DDF81760-EA47-4CB1-B44D-61E8433DE44BQ33982561-31324EA0-EE8E-459B-8854-1D92DF31061CQ34052968-67620A59-3876-419A-A9A0-B03CB6BE5E5AQ34352429-9A18E17E-4C3F-432B-A454-4DC6CB74D610Q34434913-CD0ED383-23D2-41EB-A79E-E729047CA17AQ35022585-F22C791D-5866-4A7B-9898-AB234DCC805EQ35076553-56D3133B-8353-4D1A-ADE6-70D71CC63B19Q35145382-31CEB7C7-2B9B-486D-AF5A-91A311083FB4Q35182712-1CEECE9D-0441-4B3D-96A3-B031228CFAD6Q35677445-0DDBC135-B6F2-4DD8-9456-CFA8F48104C6Q35902681-A8F43A22-20F6-4A5A-811C-661170E4E766Q36104522-8629F84C-15B2-4354-9CA7-77140B7BDC5BQ36156679-3E7608E1-87CB-479E-8818-DB8FE1D8A29CQ36263411-79BC68C7-AF03-4C76-8A09-5DA0E2CD032AQ36432758-F08B7223-A739-4A24-B709-11DF2E49DF23Q36490746-D980E80A-29B0-4209-952F-D3C97EF2AF97Q36537806-EC536FAE-82A9-4B7D-8FF4-EC08CBDA6CE2Q36807838-33E27ACA-428E-4D4B-A313-E625EED46B1EQ37162518-26D1E6E6-3DF4-448C-A1A4-7FAFF33BE261Q37252903-900120A5-FC8A-4F65-8D9C-B7DCA7100BDAQ37264399-B5379971-97C4-48A1-BA21-24B4AF9F8D61Q38688274-6A7E1548-CDFF-4B94-A256-10085898E175Q38879828-70935E6C-011E-4CA1-8011-55F14D8CD4CDQ39362365-ED090770-E5AE-44E8-8954-307261DD4642Q39402465-AEA2A30D-04FE-4665-9E70-D61D58B09BF4Q39427566-A64248C5-E331-49B7-8102-81AC03E26EF1Q39454853-B8B32B53-95C1-4BE3-A45F-8653AFBB949FQ40047192-68557229-0AD1-4A16-A896-3562004B5D54Q40169559-B073EF49-467B-4737-B68A-462808E42FC6Q40305499-AD4FC941-FC6C-41E4-9983-A32396783B70Q40706800-48FC8113-8B73-4164-A05B-4F9B4B5AA1BDQ41812539-F1CEBBF5-E686-4DC4-881D-1CBFD8D524C5Q47146547-348B5AF0-5865-470D-ABBA-D6C9A7D46176Q47552005-A84AE5A5-1DDB-4125-B2F0-2992EB776344
P2860
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@ast
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@en
type
label
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@ast
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@en
prefLabel
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@ast
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@en
P2093
P2860
P50
P356
P1476
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
@en
P2093
Nicoletta Casartelli
Romain Bouziat
Samantha Brandler
P2860
P356
10.1084/JEM.20091933
P407
P577
2009-12-28T00:00:00Z